Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells
We previously demonstrated the importance of quality management procedures for the handling of human bone marrow stromal cells (hBMSCs) and provided evidence for the existence of osteogenic inhibitor molecules in BMSCs. One candidate inhibitor is the ephrin type-A receptor 5 (EphA5), which is expres...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/1301608 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850222232268177408 |
|---|---|
| author | Tsuyoshi Yamada Toshitaka Yoshii Hiroaki Yasuda Atsushi Okawa Shinichi Sotome |
| author_facet | Tsuyoshi Yamada Toshitaka Yoshii Hiroaki Yasuda Atsushi Okawa Shinichi Sotome |
| author_sort | Tsuyoshi Yamada |
| collection | DOAJ |
| description | We previously demonstrated the importance of quality management procedures for the handling of human bone marrow stromal cells (hBMSCs) and provided evidence for the existence of osteogenic inhibitor molecules in BMSCs. One candidate inhibitor is the ephrin type-A receptor 5 (EphA5), which is expressed in hBMSCs and upregulated during long-term culture. In this study, forced expression of EphA5 diminished the expression of osteoblast phenotypic markers. Downregulation of endogenous EphA5 by dexamethasone treatment promoted osteoblast marker expression. EphA5 could be involved in the normal growth regulation of BMSCs and could be a potential marker for replicative senescence. Although Eph forward signaling stimulated by ephrin-B-Fc promoted the expression of ALP mRNA in BMSCs, exogenous addition of EphA5-Fc did not affect the ALP level. The mechanism underlying the silencing of EphA5 in early cultures remains unclear. EphA5 promoter was barely methylated in hBMSCs while histone deacetylation could partially suppress EphA5 expression in early-passage cultures. In repeatedly passaged cultures, the upregulation of EphA5 independent of methylation could competitively inhibit osteogenic signal transduction pathways such as EphB forward signaling. Elucidation of the potential inhibitory function of EphA5 in hBMSCs may provide an alternative approach for lineage differentiation in cell therapy strategies and regenerative medicine. |
| format | Article |
| id | doaj-art-72aa3fdfbb9f4b5ab79d63be28398ef9 |
| institution | OA Journals |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-72aa3fdfbb9f4b5ab79d63be28398ef92025-08-20T02:06:26ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/13016081301608Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal CellsTsuyoshi Yamada0Toshitaka Yoshii1Hiroaki Yasuda2Atsushi Okawa3Shinichi Sotome4Department of Orthopaedic and Spinal Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8510, JapanDepartment of Orthopaedic and Spinal Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8510, JapanDepartment of Orthopaedic and Spinal Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8510, JapanDepartment of Orthopaedic and Spinal Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8510, JapanSection of Regenerative Therapeutics for Spine and Spinal Cord, Tokyo Medical and Dental University, Tokyo 113-8510, JapanWe previously demonstrated the importance of quality management procedures for the handling of human bone marrow stromal cells (hBMSCs) and provided evidence for the existence of osteogenic inhibitor molecules in BMSCs. One candidate inhibitor is the ephrin type-A receptor 5 (EphA5), which is expressed in hBMSCs and upregulated during long-term culture. In this study, forced expression of EphA5 diminished the expression of osteoblast phenotypic markers. Downregulation of endogenous EphA5 by dexamethasone treatment promoted osteoblast marker expression. EphA5 could be involved in the normal growth regulation of BMSCs and could be a potential marker for replicative senescence. Although Eph forward signaling stimulated by ephrin-B-Fc promoted the expression of ALP mRNA in BMSCs, exogenous addition of EphA5-Fc did not affect the ALP level. The mechanism underlying the silencing of EphA5 in early cultures remains unclear. EphA5 promoter was barely methylated in hBMSCs while histone deacetylation could partially suppress EphA5 expression in early-passage cultures. In repeatedly passaged cultures, the upregulation of EphA5 independent of methylation could competitively inhibit osteogenic signal transduction pathways such as EphB forward signaling. Elucidation of the potential inhibitory function of EphA5 in hBMSCs may provide an alternative approach for lineage differentiation in cell therapy strategies and regenerative medicine.http://dx.doi.org/10.1155/2016/1301608 |
| spellingShingle | Tsuyoshi Yamada Toshitaka Yoshii Hiroaki Yasuda Atsushi Okawa Shinichi Sotome Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells Stem Cells International |
| title | Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells |
| title_full | Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells |
| title_fullStr | Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells |
| title_full_unstemmed | Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells |
| title_short | Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells |
| title_sort | dexamethasone regulates epha5 a potential inhibitory factor with osteogenic capability of human bone marrow stromal cells |
| url | http://dx.doi.org/10.1155/2016/1301608 |
| work_keys_str_mv | AT tsuyoshiyamada dexamethasoneregulatesepha5apotentialinhibitoryfactorwithosteogeniccapabilityofhumanbonemarrowstromalcells AT toshitakayoshii dexamethasoneregulatesepha5apotentialinhibitoryfactorwithosteogeniccapabilityofhumanbonemarrowstromalcells AT hiroakiyasuda dexamethasoneregulatesepha5apotentialinhibitoryfactorwithosteogeniccapabilityofhumanbonemarrowstromalcells AT atsushiokawa dexamethasoneregulatesepha5apotentialinhibitoryfactorwithosteogeniccapabilityofhumanbonemarrowstromalcells AT shinichisotome dexamethasoneregulatesepha5apotentialinhibitoryfactorwithosteogeniccapabilityofhumanbonemarrowstromalcells |